About BeneVet Oncology

Advancing Cancer Care Because Pets Are Family

BeneVet is a biotechnology company dedicated to transforming veterinary oncology through cutting-edge science and compassionate care. Our team includes veterinary oncologists, pharmaceutical innovators, and passionate animal advocates, united by a shared goal — giving pets the chance to live longer, healthier lives. Leveraging nanotechnology, polymer science, and potent oncology drugs, BeneVet is developing cancer therapies that are both safe and effective for companion animals. Unlike most chemotherapies, which cats often cannot tolerate, our investigational therapy PRV131 has shown no reported toxicity or weight loss, even after multiple intratumoral injections in feline patients — offering new hope in the treatment of cancer in cats.

Click on an image below to learn more

Micah Beast Mauri Callie Fang
Lexi Laverne Sam Sissy Gracie
Dog and woman at park

Why this matters

Animals Need Our Protection

Cancer affects more than 6 million dogs and cats each year in the United States alone. Treatments for animals are lagging far behind human cancer therapies. BeneVet is working to change that, and we believe that with your support, we can bring new hope to pet owners and their beloved companions.